However, CTL infiltrates are present in both MSI and microsatellite stable (MSS) human colon carcinoma [5], suggesting that other immune checkpoints may compensate for PD-L1 function in suppression of tumor-infiltrating CTL effector function in human colorectal carcinoma [4]. This evidence concerns the gene CD274 and colorectal carcinoma.